Showing results (1-10 of 249) with videos related to
Sort By:
Pageof 25
BMC Medical Research Methodology|January 21, 2022
Practical recommendations for implementing a Bayesian adaptive phase I design during a pandemicSean Ewings, Geoff Saunders, Thomas Jaki, et al.Journal of the Royal Statistical Society. Series C, Applied Statistics|April 23, 2019
An information theoretic phase I-II design for molecularly targeted agents that does not require an assumption of monotonicityPavel Mozgunov, Thomas JakiStatistics in Medicine|December 21, 2019
Improving safety of the continual reassessment method via a modified allocation rulePavel Mozgunov, Thomas JakiBiometrical Journal. Biometrische Zeitschrift|July 13, 2019
A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpointsPavel Mozgunov, Thomas JakiBiostatistics (Oxford, England)|August 31, 2018
A benchmark for dose finding studies with continuous outcomesPavel Mozgunov, Thomas Jaki, Xavier PaolettiStatistical Methods in Medical Research|April 28, 2020
A surface-free design for phase I dual-agent combination trialsPavel Mozgunov, Mauro Gasparini, Thomas JakiStatistics in Medicine|May 9, 2023
A Bayesian multi-arm multi-stage clinical trial design incorporating information about treatment orderingAlessandra Serra, Pavel Mozgunov, Thomas JakiBiometrical Journal. Biometrische Zeitschrift|June 13, 2020
Using a dose-finding benchmark to quantify the loss incurred by dichotomization in Phase II dose-ranging studiesPavel Mozgunov, Thomas Jaki, Xavier PaolettiStatistics in Medicine|January 20, 2022
An order restricted multi-arm multi-stage clinical trial designAlessandra Serra, Pavel Mozgunov, Thomas JakiJournal of Biopharmaceutical Statistics|October 24, 2018
Randomized dose-escalation designs for drug combination cancer trials with immunotherapyPavel Mozgunov, Thomas Jaki, Xavier PaolettiPageof 25